The Company’s therapeutic focus is on onology, neurology and immunology and the development of orphan drugs. Ergomed Plc manages clinical development from Phase I through to late phase programs. The Company operates in two segments: The services business and the co-development business. The clinical development services offered by the Company include study management, site management, study physician support, safety services, regulatory and quality management, clinical data management and biostatistics, and medical writing. It has planned, managed, monitored, and reported clinical trials with a range of technologies that include small molecule drugs, monoclonal antibodies, tri-functional antibodies, soluble receptors, cancer vaccines and immunotherapy, radioactive agents, and photodynamic therapies. The Company also has co-development deals with other companies.
Guildford, GB
Size (employees)
150 (est)
Ergomed is headquartered in Guildford, GB

Ergomed Office Locations

Ergomed has an office in Guildford
Guildford, GB (HQ)
26 Frederick Sanger Rd
Show all (1)

Ergomed Financials and Metrics

Ergomed Financials

Ergomed's revenue was reported to be £39.2 m in FY, 2016 which is a 30% increase from the previous period.

Revenue (FY, 2016)

39.2 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

12 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

479 k

Market capitalization (31-Oct-2017)

85.1 m

Closing share price (31-Oct-2017)


Cash (31-Dec-2016)

4.4 m
Ergomed's current market capitalization is £85.1 m.
GBPFY, 2013FY, 2014FY, 2015FY, 2016


15.1 m21.2 m30.2 m39.2 m

Revenue growth, %


Cost of goods sold

10.1 m15.4 m21.8 m27.2 m

Gross profit

5 m5.8 m8.4 m12 m
GBPFY, 2013FY, 2014FY, 2015FY, 2016


2 m4.6 m4 m4.4 m

Accounts Receivable

2.3 m4.7 m6.4 m9.5 m

Current Assets

5.2 m10.9 m13.5 m19.8 m


150 k547 k883 k2.4 m
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Cash From Operating Activities

1.4 m537 k264 k(2.4 m)

Cash From Financing Activities

(68 k)9.1 m(1 k)8.7 m

Income Taxes Paid

(232 k)(199 k)(520 k)153 k
Y, 2016

Financial Leverage

1.6 x
Show all financial metrics

Ergomed Operating Metrics

Ergomed's Customers was reported to be 100 in FY, 2015
FY, 2015



Patients Studied

30 k


Show all operating metrics

Ergomed Market Value History

Ergomed Revenue Breakdown

Ergomed's Web-traffic and Trends

Ergomed News and Updates

City Moves for 18 December 2017 - who's switching jobs?

Today's City Moves cover investing, equities research and pharma. Take a look at these movers and shakers: Burford Capital Elizabeth O’Connell has been appointed as Burford’s chief financial officer. Elizabeth has been a Burford managing director since its inception in 2009, managing its inves…

City Moves - who's switching jobs?

Today's City Moves cover investments,finance and advisory and pharmaceuticals. Take a look at these movers and shakers: Chartered Institute for Securities & Investment Edward Loader has been appointed president of the Chartered Institute for Securities & Investment (CISI) Jersey branch…

Ergomed Company Life and Culture

You may also be interested in